Adverse cutaneous drug reactions among hospitalized patients: Five year surveillance

Cutaneous and Ocular Toxicology

Volumn 32, Issue 1, 2013, Pages 41-45

  Turk, Bengu Gerceker ^a   Gunaydin, Asli ^a   Ertam, Ilgen ^a   Ozturk, Gunseli ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adverse drug reaction; Cutaneous; Hospitalized patients

Indexed keywords

ADALIMUMAB; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CEFALEXIN; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; CLINDAMYCIN; CONTRAST MEDIUM; COTRIMOXAZOLE; DAUNORUBICIN; DICLOFENAC; ETODOLAC; FLUDARABINE; FLURBIPROFEN; FUSIDATE SODIUM; IBUPROFEN; IMATINIB; LEVOFLOXACIN; MEBEVERINE; MELOXICAM; NAPROXEN; PARACETAMOL; PHENYLEPHRINE; PSEUDOEPHEDRINE; SULTAMICILLIN; TERBINAFINE; UNINDEXED DRUG;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BULLOUS SKIN DISEASE; CHILD; CLINICAL FEATURE; CUTANEOUS ADVERSE DRUG REACTION; CUTANEOUS ADVERSE SKIN REACTION; DRESS SYNDROME; DRUG INDUCED DISEASE; ERYTHEMA MULTIFORME; ERYTHRODERMA; FEMALE; HOSPITAL PATIENT; HUMAN; INFANT; LICHENOID ERUPTION; MAJOR CLINICAL STUDY; MALE; MEASLES LIKE RASH; MOUTH LESION; OUTCOME ASSESSMENT; PANNICULITIS; PRESCHOOL CHILD; PSORIASIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN DISEASE; STEVENS JOHNSON SYNDROME; UNIVERSITY HOSPITAL; URTICARIA; VASCULITIS;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; TURKEY; YOUNG ADULT;

EID: 84868521008     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2012.702837     Document Type: Article

References (22)

1. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986;256:3358-3363
2. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-770
3. Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J 2010;51:767-774
4. Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: A 5-year experience. J Am Acad Dermatol 2008;59:995-999
5. Ding YW, Lee KC, Choon ES. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2010;49:834-841
6. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents-a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95-99
7. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-1259
8. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123-129
9. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-846
10. Guidelines for the RegiSCAR Study. September 2009. Available at: http://regiscar.uni-freiburg.de
11. Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430
12. Apaydin R, Bilen N, Dökmeci S, Bayramgürler D, Yildirim G. Drug eruptions: A study including all inpatients and outpatients at a dermatology clinic of a university hospital. J Eur Acad Dermatol Venereol 2000;14:518-520
13. Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: A 1-year study at Ramathibodi Hospital. Int J Dermatol 1998;37:747-751
14. Barbaud A, Reichert-Penetrat S, Tréchot P, Jacquin-Petit MA, Ehlinger A, Noirez V et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58
15. Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res 2006;37:899-902
16. Adisen E, Karaca F, Gurer AM. Dermatolojide ilaç reaksiyonlari. J Dermatol 2008;2:1-5
17. Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol 2011;67:463-470
18. Li LF, Ma C. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 2006;31:642-647
19. Teraki Y, Shibuya M, Izaki S. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Clin Exp Dermatol 2010;35:723-728
20. Huang HY, Luo XQ, Chan LS, Cao ZH, Sun XF, Xu JH. Cutaneous adverse drug reactions in a hospital-based Chinese population. Clin Exp Dermatol 2011;36:135-141
21. Atzori L, Pinna AL, Mantovani L, Ferreli C, Pau M, Mulargia M et al. Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department - cagliari university (Italy). J Eur Acad Dermatol Venereol 2011;Oct 24. [Epub ahead of print].
22. Aihara M. Pharmacogenetics of cutaneous adverse drug reactions. J Dermatol 2011;38:246-254.